Manzo Pharmaceuticals, Inc. (MNZO)

Manzo Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2004	FY 2003	FY 2002
Period Ending	Sep 30, 2005	Dec 31, 2004	Dec 31, 2003	Dec 31, 2002
Cash & Equivalents	0.01	0.01	0.01	-
Cash & Short-Term Investments	0.01	0.01	0.01	-
Cash Growth	-42.63%	-18.78%	-	-
Other Receivables	2.68	3.14	3.11	-
Receivables	2.68	3.14	3.11	-
Inventory	-	-	1.44	-
Other Current Assets	0.5	0.14	0.14	-
Total Current Assets	3.18	3.28	4.71	-
Property, Plant & Equipment	0.8	1.14	3.39	-
Total Assets	4.05	4.43	8.1	-
Accounts Payable	5.6	11.86	11	-
Accrued Expenses	1.29	3.52	2.56	-
Short-Term Debt	5.12	6.52	7.31	-
Current Income Taxes Payable	3.62	4.62	5.25	-
Other Current Liabilities	0.16	0.4	0.43	-
Total Current Liabilities	15.79	26.93	26.56	-
Total Liabilities	15.79	26.93	26.56	-
Common Stock	0.05	0.03	0.03	-
Additional Paid-In Capital	10.82	8.86	8.74	-
Retained Earnings	-22.58	-31.37	-27.22	-
Comprehensive Income & Other	-0.03	-0.02	-0.01	-
Shareholders' Equity	-11.74	-22.5	-18.46	-
Total Liabilities & Equity	4.05	4.43	8.1	-
Total Debt	5.12	6.52	7.31	-
Net Cash (Debt)	-5.11	-6.51	-7.3	-
Net Cash Per Share	-1.29	-1.88	-2.27	-
Filing Date Shares Outstanding	5.25	5.25	3.37	2.8
Total Common Shares Outstanding	5.25	3.49	3.37	2.8
Working Capital	-12.6	-23.65	-21.86	-
Book Value Per Share	-2.24	-6.45	-5.48	-
Tangible Book Value	-11.74	-22.5	-18.46	-
Tangible Book Value Per Share	-2.24	-6.45	-5.48	-
Land	3.18	10.61	10.61	-
Machinery	0.61	0.12	3.02	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.